(6aS,11bR)-6a,11b-Dihydro-5,6a,9-trihydroxy-2,2-dimethyl-11b-(3-methyl-2-butenyl)-2H,6H-benzofuro[3,2-b]pyrano[3,2-g][1]benzopyran-6-one;Sanggenon A;Sanggenone A
Sanggenon A exhibits anti-inflammatory effects by modulating the NF-κB and HO-1/Nrf2 signaling pathways in BV2 and RAW264.7 cells; it significantly inhibits lipopolysaccharide (LPS)-induced nitric oxide production.